Orion Nutraceuticals Clarifies Name Change Announcement
(TheNewswire)
September 5, 2025 – TheNewswire- Vancouver, British Columbia - Orion Nutraceuticals Inc. (CSE: ORI ) (the “ Company ”) wishes to clarify its news releasedated September 4, 2025 regarding the Company’s proposed name changeand share consolidation.
The Company previously announced incorrectly that itwould be changing its name to Pinetree Ventures Corp. The Companyconfirms that the new name will be Pinetown Ventures Corp. (the“ Name Change ”).
As disclosed, the Name Change will be effective onTuesday, September 9, 2025, in conjunction with the previouslyannounced share consolidation (the “ Consolidation ”).All other terms of the Consolidation remain unchanged as described inthe Company’s September 4, 2025 news release.
The new CUSIP number for the common shares of theCompany will be 723328209 and the new ISIN number will beCA7233282093.
On behalf of the Board of Directors of:
Orion Nutraceuticals Inc.
Guy Bourgeois, Director
Tel: ( 604) 687-2038
Information set forth in this press release may involveforward-looking statements. Forward-looking statements are statementsthat relate to future, not past, events. In this context,forward-looking statements often address a company’s expected futurebusiness and financial performance, and often contain words such as“anticipate”, “believe”, “plan”, “estimate”,“expect”, and “intend”, statements that an action or event“may”, “might”, “could”, “should”, or “will” betaken or occur, or other similar expressions. By their nature, forward-lookingstatements involve known and unknown risks, uncertainties and otherfactors which may cause our actual results, performance orachievements, or other future events, to be materially different fromany future results, performance or achievements expressed or impliedby such forward-looking statements. Such factorsinclude, among others, the following risks: the need for additionalfinancing; reliance on key personnel; and the potential for conflictsof interest among certain officers or directors with certain otherprojects. Forward-looking statements are made based on management’sbeliefs, estimates and opinions on the date that statements are madeand except as required by law, the Company undertakes no obligation toupdate forward-looking statements if these beliefs, estimates andopinions or other circumstances should change. Investors are cautionedagainst attributing undue certainty to forward-looking statements. Forfurther information on risk, investors are advised to see theCompany’s MD&A and other disclosure filings with the regulatorswhich are found at www.sedarplus.ca.
Copyright (c) 2025 TheNewswire - All rights reserved.
NASDAQ: ORONF
ORONF Trading
0.0% G/L:
$0.2862 Last:
400 Volume:
$0.2862 Open:



